Using routine diagnostic data as a method of surveillance of arboviral infection in travellers: a comparative analysis with a focus on dengue.
暂无分享,去创建一个
Chantal Reusken | Marion Koopmans | M. Koopmans | C. Reusken | M. D. de Jong | N. Cleton | J. Reimerink | A. A. van der Eijk | Johan Reimerink | J. Murk | Annemiek van der Eijk | Menno de Jong | Natalie Cleton | Jean-Luc Murk
[1] J. Gaudart,et al. Multicenter EuroTravNet/GeoSentinel Study of Travel-related Infectious Diseases in Europe , 2009, Emerging infectious diseases.
[2] E. Caumes,et al. Illnesses in travelers returning from the tropics: a prospective study of 622 patients. , 2006, Journal of travel medicine.
[3] G. Chang,et al. Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes , 2004, Journal of Virology.
[4] M. Cetron,et al. Spectrum of disease and relation to place of exposure among ill returned travelers. , 2006, The New England journal of medicine.
[5] S. Weaver,et al. The history and evolution of human dengue emergence. , 2008, Advances in virus research.
[6] M. Wilson,et al. The traveller and emerging infections: sentinel, courier, transmitter , 2003, Journal of applied microbiology.
[7] A. Amarilla,et al. Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization. , 2010, Biologicals : journal of the International Association of Biological Standardization.
[8] T. van Gool,et al. Travel-related Dengue Virus Infection, the Netherlands, 2006–2007 , 2011, Emerging infectious diseases.
[9] H. Doerr,et al. Cross-reactivity in flavivirus serology: new implications of an old finding? , 2002, Medical Microbiology and Immunology.
[10] E. Gould,et al. Impact of climate change and other factors on emerging arbovirus diseases. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[11] A. Barrett,et al. Transmission cycles, host range, evolution and emergence of arboviral disease , 2004, Nature Reviews Microbiology.
[12] Mary E. Wilson,et al. Etiology of travel-related fever , 2007, Current opinion in infectious diseases.
[13] Cameron P Simmons,et al. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. , 2010, Cell host & microbe.
[14] M. Koopmans,et al. Underdiagnosis of chikungunya virus infections in symptomatic dutch travelers returning from the Indian ocean area. , 2013, Journal of travel medicine.
[15] Mary E. Wilson,et al. Fever in returned travelers: results from the GeoSentinel Surveillance Network. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] J. Castellanos,et al. Dengue-yellow fever sera cross-reactivity; challenges for diagnosis. , 2008, Revista de salud publica.
[17] Robert V. Tauxe,et al. Public Health Surveillance: A Tool for Targeting and Monitoring Interventions , 2006 .
[18] N. Karabatsos,et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. , 1989, The Journal of general virology.
[19] C. Lai,et al. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. , 1996, Virology.
[20] K. Henning,et al. What is syndromic surveillance? , 2004, MMWR supplements.
[21] R. Allwinn. Significant increase in travel-associated dengue fever in Germany , 2011, Medical Microbiology and Immunology.
[22] H. Doerr,et al. Dengue in Travellers Is Still Underestimated , 2008, Intervirology.
[23] P. Desprès,et al. Chikungunya Virus, Southeastern France , 2011, Emerging infectious diseases.
[24] Mary E. Wilson,et al. Dengue and chikungunya infections in travelers , 2010, Current opinion in infectious diseases.
[25] L. Ng,et al. Chikungunya: a bending reality. , 2009, Microbes and infection.
[26] M. Moroni,et al. Prospective observational study of fever in hospitalized returning travelers and migrants from tropical areas, 1997-2001. , 2006, Journal of travel medicine.
[27] K. Leder,et al. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] A. Barrett,et al. Flavivirus-induced antibody cross-reactivity , 2011, The Journal of general virology.
[29] Timothy S Baker,et al. Conformational changes of the flavivirus E glycoprotein. , 2004, Structure.
[30] F. Cobelens,et al. Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia , 2002, Tropical medicine & international health : TM & IH.
[31] Natasha L. Tilston,et al. Pan-European Chikungunya surveillance: designing risk stratified surveillance zones , 2009, International journal of health geographics.
[32] Eva Harris,et al. Global spread and persistence of dengue. , 2008, Annual review of microbiology.
[33] Eli Schwartz,et al. Dengue in travelers. , 2005, The New England journal of medicine.
[34] N. Beeching,et al. Fever in returned travellers presenting in the United Kingdom: recommendations for investigation and initial management. , 2009, The Journal of infection.
[35] K. Stiasny,et al. Cryptic Properties of a Cluster of Dominant Flavivirus Cross-Reactive Antigenic Sites , 2006, Journal of Virology.
[36] J. Eslava-Schmalbach,et al. Revista de Salud Pública , 2011 .
[37] A. M. Kilpatrick,et al. Globalization, Land Use, and the Invasion of West Nile Virus , 2011, Science.